Precision medicine


There are approximately 60 000 individuals diagnosed with cancer (new cases) per year in Sweden, and approximately 12 million world-wide.

BioReperia have in collaboration with clinicians demonstarted that our unique platform enable identification of efficious anti-cancer therapies costumized to the individual cancet patient´s need within 5 days. This will allow patients to receive the most efficecious treatment avalible, thus improving prognosis and reducing costs reltaed to failed treatments.

Currently we are conducting a clinical trial together with suregeons from Region Östergötland and researchers at Linköping University to further validate and improve our model.